We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

94 hedge funds and large institutions have $855M invested in Stoke Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more capital invested

Capital invested by funds: $492M → $855M (+$362M)

43.66% more ownership

Funds ownership: 52.67% → 96.33% (+44%)

32% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 25

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

4% more funds holding

Funds holding: 90 → 94 (+4)

Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
1.45%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
20
Increased
33
Reduced
25
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
+$11.6M
2
CAC
Cowen and Company
New York
+$6.19M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.58M
4
ABG
Ally Bridge Group
New York
+$4.41M
5
FPCP
Fort Point Capital Partners
California
+$3.82M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$3.23M
2
State Street
State Street
Massachusetts
-$2.81M
3
TCM
Tekla Capital Management
Massachusetts
-$2.52M
4
CAM
Cormorant Asset Management
Massachusetts
-$2.29M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Casdin Capital
New York
$2.88M – – –
VOYA Investment Management
27
VOYA Investment Management
Georgia
$1.98M -$11.3K -472 -0.6%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$1.73M +$654K +27,423 +61%
Victory Capital Management
29
Victory Capital Management
Texas
$1.59M +$303K +12,689 +24%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.48M +$45.9K +1,924 +3%
Citigroup
31
Citigroup
New York
$1.31M +$356K +14,927 +37%
Bank of America
32
Bank of America
North Carolina
$1.29M +$1.08M +45,345 +540%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$1.11M +$332K +13,926 +43%
UBS Group
34
UBS Group
Switzerland
$1.04M +$250K +10,464 +32%
N
35
Nuveen
North Carolina
$1.02M -$111K -4,672 -8%
AA
36
ALPS Advisors
Colorado
$1.02M -$58.8K -2,463 -5%
Marshall Wace
37
Marshall Wace
United Kingdom
$1.02M +$1.01M +42,401 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$960K -$981K -41,100 -51%
TD Asset Management
39
TD Asset Management
Ontario, Canada
$833K +$134K +5,600 +19%
SG Americas Securities
40
SG Americas Securities
New York
$730K -$271K -11,372 -27%
Swiss National Bank
41
Swiss National Bank
Switzerland
$677K – – –
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$674K +$168K +7,042 +33%
TI
43
Trexquant Investment
Connecticut
$633K +$630K +26,399 New
GCP
44
GSA Capital Partners
United Kingdom
$587K +$351K +14,714 +151%
Deutsche Bank
45
Deutsche Bank
Germany
$584K -$68.3K -2,864 -11%
Barclays
46
Barclays
United Kingdom
$556K +$334K +14,000 +153%
Two Sigma Investments
47
Two Sigma Investments
New York
$540K -$1.38M -58,022 -72%
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$539K +$536K +22,480 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$511K +$11.5K +483 +2%
AllianceBernstein
50
AllianceBernstein
Tennessee
$475K +$28.6K +1,200 +6%
1
2
3 4 5

STOK Hedge Fund Activity: Q4 2021 in Review

94 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q4 2021, worth a combined $855M — up 74% from $492M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new STOK positions and 16 closed out — a net gain of 4 holders — while 33 added to existing stakes and 25 trimmed.

The largest buyer was Octagon Capital Advisors, adding an estimated $11.6M. The largest seller was Redmile Group, cutting an estimated $3.23M.

  • 94 institutional investors held Stoke Therapeutics (STOK) as of Q4 2021, up from 90 in Q3 2021.
  • Funds reported $855M of Stoke Therapeutics stock for Q4 2021, up 74% quarter-over-quarter.
  • 20 funds opened new Stoke Therapeutics positions in Q4 2021 and 16 closed out, a net change of +4 holders.
  • The largest Stoke Therapeutics buyer in Q4 2021 was Octagon Capital Advisors, an estimated $11.6M added.
  • The largest Stoke Therapeutics seller in Q4 2021 was Redmile Group, an estimated $3.23M sold.

Based on aggregated 13F filings for Q4 2021.